Details for New Drug Application (NDA): 020122
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in NIPENT is pentostatin. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentostatin profile page.
Summary for 020122
Tradename: | NIPENT |
Applicant: | Hospira Inc |
Ingredient: | pentostatin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 020122
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 020122
Suppliers and Packaging for NDA: 020122
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NIPENT | pentostatin | INJECTABLE;INJECTION | 020122 | NDA | Hospira, Inc. | 0409-0801 | 0409-0801-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0801-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/VIAL | ||||
Approval Date: | Oct 11, 1991 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 020122
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hospira Inc | NIPENT | pentostatin | INJECTABLE;INJECTION | 020122-001 | Oct 11, 1991 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription